Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord. SE CONNECTER À UN COMPTE LECTEUR CRÉER UN COMPTE LECTEUR
Conformis Reports Third Quarter 2020 Financial Results
04 nov. 2020 16h10 HE
|
Conformis, Inc.
BILLERICA, Mass., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the third quarter ended September 30, 2020. Third Quarter 2020 Summary Total...
Conformis, Inc. to Participate in the 2020 Oppenheimer Fall MedTech Summit
28 oct. 2020 18h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer,...
North America, Asia Pacific & European Union Robotic-Assisted Surgery Regulatory and Reimbursement Scenario Report 2020
21 oct. 2020 03h43 HE
|
Research and Markets
Dublin, Oct. 21, 2020 (GLOBE NEWSWIRE) -- The "Regulatory and Reimbursement Scenario of Robotic-Assisted Surgery" report has been added to ResearchAndMarkets.com's offering. The scope of this...
Conformis Reports Preliminary Third Quarter Revenue Results
06 oct. 2020 07h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced preliminary, unaudited, revenue results for the third quarter ended September 30, 2020. Expected...
Conformis Announces 510(k) Clearance for Cordera™ Hip System
29 sept. 2020 10h45 HE
|
Conformis, Inc.
BILLERICA, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration of the Company’s new Cordera™ Hip...
Conformis, Inc. Announces $17.25 Million Registered Direct Offering Priced At-The-Market
24 sept. 2020 07h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Sept. 24, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (Nasdaq: CFMS) today announced it has entered into a definitive agreement with a healthcare focused institutional investor to...
Conformis, Inc. to Present at the 2020 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
16 sept. 2020 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) will participate in the 2020 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit being held September...
Conformis, Inc. to Present at the 2020 H.C. Wainwright Global Investment Conference
08 sept. 2020 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) will participate in the upcoming 2020 H.C. Wainwright 22nd Annual Global Investment Conference, to be held...
Conformis Reports Second Quarter 2019 Financial Results and Updates Product Revenue Expectations
31 juil. 2019 16h05 HE
|
Conformis, Inc.
BILLERICA, Mass., July 31, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop,...
Conformis Secures Up to $30 Million in Debt Financing and $3 Million in Equity Financing from Innovatus Life Sciences and East West Bank
25 juin 2019 16h15 HE
|
Conformis, Inc.
BILLERICA, Mass., June 25, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop,...